Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haploidentical Stem Cell Transplantation Followed by NK Cell Infusion in Patients With High-risk Solid Tumors Who Failed Autologous Stem Cell Transplantation

NCT01807468 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01807468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01807468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haploidentical Stem Cell Transplantation Followed by NK Cell Infusion in Patients With High-risk Solid Tumors Who Failed Autologous Stem Cell Transplantation
Lead sponsor
Samsung Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2013
Completion date
June 30, 2019
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ewing sarcoma, neuroblastoma, osteosarcoma, rhabdomyosarcoma, soft tissue sarcoma